Actively Recruiting
External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population
Led by Hôpital Universitaire Sahloul · Updated on 2025-07-28
250
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to validate the Glasgow-Blatchford Score (GBS) in adults presenting with non-traumatic upper gastrointestinal bleeding in Tunisia. The study addresses the challenge of routinely hospitalizing all patients for observation by evaluating whether GBS can accurately predict risks like rebleeding, the need for hemostatic treatment, complications, and mortality within 30 days. It is a multicenter, descriptive, and analytical observational study conducted in emergency departments. Adult patients aged 18 years and older with non-traumatic upper gastrointestinal bleeding will be included. Clinical and epidemiological information will be collected using a standard form that incorporates GBS criteria. Follow-up will occur 30 days after initial presentation to track adverse outcomes including rebleeding, need for intervention, complications, and death. The performance of the GBS will be assessed statistically for sensitivity, specificity, and predictive values. Participants will have their clinical data recorded at emergency department visits. A telephone follow-up at 30 days will gather information about any complications or mortality. Researchers will analyze the data to determine how well the GBS predicts outcomes in this population. The total duration of involvement per participant will be approximately 30 days, with confidentiality and informed consent ensured throughout the study.
CONDITIONS
Brief Title
External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (aged 18 years or older) presenting with non-traumatic upper gastrointestinal bleeding
You will not qualify if you...
- Patients under 18 years of age
- Diagnosis of external hemorrhoids with mucosal lesions
- Patients who do not consent to participate
- Patients lost to follow-up
- Patients with incomplete data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Initial emergency department visit
Participants presenting with upper gastrointestinal bleeding have their clinical data collected, including the Glasgow-Blatchford Score criteria, to assess bleeding severity and risk.
1 visit (in-person)
Duration - 30 days
Participants are followed up via telephone for 30 days to record any adverse events such as rebleeding, need for hemostatic intervention, complications, and mortality.
1 follow-up call
Trial Site Locations
Total: 1 location
1
Sahloul University Hospital
Sousse, Tunisia, 4021
Actively Recruiting
Research Team
R
Riadh Boukef, Professor
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here